# Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

> **NCT04076449** · — · RECRUITING · sponsor: **yuanli Zhao** · enrollment: 200 (estimated)

## Conditions studied

- Cavernous Malformation, Cerebral
- Cavernous Angioma
- Cavernous Hemangioma
- Cavernous Hemangioma of Brain
- Seizures
- Seizures, Epileptic
- Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04076449
- **Lead sponsor:** yuanli Zhao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04076449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04076449, "Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04076449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*